Rosetta Inpharmatics (RSTA) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Rosetta Inpharmatics (RSTA)

An SI Board Since August 2000

Posts	SubjectMarks	Bans	Symbol
31	4	0	RSTA

Emcee: greedsgd_2000	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
31	April 25, 2001--Rosetta Inpharmatics, Inc. (Nasdaq:RSTA - news) today announced	nigel bates	-	4/25/2001
30	Minor correction to previous post: memory not serving; I don't think Dr. Hoo	tuck	-	4/23/2001
29	From BioOnline, a panel discussion concerning the standardization of microarray	tuck	-	4/23/2001
28	KIRKLAND, Wash.--(BUSINESS WIRE)--April 18, 2001--Rosetta Inpharmatics, Inc. (Na	nigel bates	-	4/18/2001
27	The Article from Feb 15 Nature: nature.com You might have to register. Cheers	tuck	-	3/30/2001
26	SIGNALSmag article with prominent mention of RSTA and the article you referenced	tuck	-	3/10/2001
25	Feb. 11, 2001--Rosetta Inpharmatics (NASDAQ:RSTA - news) today announced the pub	nigel bates	-	2/12/2001
24	forget that last post I found what i was looking for. Another question:has the	jj_	-	2/4/2001
23	collaborations? I used to have the best pre-ipo site bookmarked that would rate	jj_	-	2/4/2001
22	The recent news about stricter laws governing patents should be a POSITIVE for t	Dan Spillane	-	1/17/2001
21	<If you try to attach a logical reason to every stock movement, you will quic	Elmer	-	12/16/2000
20	I think it's tax loss selling. It has few institutional holders and nobody w	Elmer	-	12/12/2000
19	Absolutely no idea (nb my knowledge of Rosetta is pretty sketchy). If you try t	nigel bates	-	12/11/2000
18	nigel, This is strange, indeed. A solid day in the markets, including biotech.	tuck	-	12/11/2000
17	Looking at this puppy for bioinformatics section of Trickle portfolio. One thin	tuck	-	12/3/2000
16	My understanding is the Rosetta software is unique in approach and can analyze e	Dan Spillane	-	11/30/2000
15	Nov. 30, 2000-- Rosetta Inpharmatics, Inc. (Nasdaq:RSTA - news) today announced	nigel bates	-	11/30/2000
14	<i>No one is noticing this</i> Fairly or unfairly, agritech is rathe	nigel bates	-	11/29/2000
13	Hey this new Monsanto agreement includes royalties. Those could be huge--the cro	Dan Spillane	-	11/29/2000
12	KIRKLAND, Wash. and CAMBRIDGE, UK--(BW HealthWire)--Nov. 8, 2000-- Companies co	nigel bates	-	11/8/2000
11	SEATTLE TIMES ARTICLE ON RSTA Sunday, November 05, 2000, 12:00 a.m. Pacific Cr	greedsgd_2000	-	11/6/2000
10	Oxford Glyco/Rosetta - the key connection. Oxford Glyco Science is the world le	greedsgd_2000	-	11/5/2000
9	Here is that article from Red Herring: November 5, 2000 Trend number t	greedsgd_2000	-	11/5/2000
8	Check out the 12/4/00 issue of Red Herring Magazine, currently available online.	akoni-1	-	11/4/2000
7	Chips Ahoy Zina Moukheiber, Forbes Magazine, 11.13.00 IN A BUILDING STILL UNDER	greedsgd_2000	-	11/2/2000

Go to reply# or date (mm/dd/yy):